Anti-Platelets in Chronic Obstructive Pulmonary Disease
Status:
Not yet recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
This is a 6 week crossover study in smokers with and without COPD to evaluate whether 2 weeks
of dual antiplatelet therapy (aspirin 81mg and clopidogrel 75mg) improves pulmonary perfusion
(i.e. blood flow in the lungs measured on a contrast CT scan) compared to placebo.